The results of these studies demonstrated that treatment significantly reduced the levels of MMP-8, PGE2, IL-6, and t-PA in the GCF of RA patients; however, the systemic biomarkers of RA (ESR, CRP and RF) were not improved. Here, CRP is linked to rheumatoid arthritis.